Delivery Order SPE2DR25D1053-SPE2DR26FT535
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,409.22 to AmerisourceBergen Drug Corp for Provocholine inhalation solution pack (18mL) on September 23, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a ceiling value of $2,601.79. This competitive award, made without a set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The order is expected to be completed by August 27, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18mL pack configuration, valued at $1,100.26 under a firm fixed-price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order represents a purchase of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,039.43 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance in Conshohocken, Pennsylvania and completion scheduled for November 5, 2025. This is a firm fixed-price delivery order issued without set-aside designation, reflecting competitive award to the prime contractor based on open competition capabilities. The delivery order represents a child action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Provocholine Inhalation Solution in 18ml pack quantities, with a contract ceiling value of $9,767.18. This non-competitive delivery order represents a firm fixed price transaction with a completion date of October 24, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $2,750.65 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Provocholine Inhalation Solution in 18 mL packs. This is a firm fixed-price contract with a completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- This delivery order, awarded on July 23, 2025, procures Provocholine inhalation solution in 18ML pack quantities for the Defense Department's Medical Supply Chain with a ceiling value of $6,732.76. The award is issued under firm fixed pricing with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected as the awardee through competitive procurement with no set-aside designation. This delivery order is issued as a...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT535Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,459.23 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of November 4, 2025. This contract was competitively awarded without set-aside designation and utilizes firm fixed price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 million through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply procurement across the Defense Health System. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through a diverse portfolio of medications, vaccines, medical devices, and specialized healthcare commodities. The company's track record of managing competitively awarded contracts with consistent firm fixed pricing demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/3/25 |